Serious Transfusion Incident Report (STIR) for the period…

December 1, 2023

Blood Matters are pleased to announce the publication of the Serious Transfusion Incident Report (STIR) for the period 1 July 2021 to 30 June 2022 (FY22) is available on the…

Read More

CSL Prof Heimburger Award 2024

October 18, 2023

This may be of interest to members. CSL are delighted to announce that applications for the Prof Heimburger Award 2024 opened on August 1, 2023.   The Prof Heimburger Award…

Read More

National Blood Authority transition of plasma products

October 17, 2023

This may be of interest to members.   In May 2022, the National Blood Authority (NBA) announced that 5 domestically produced plasma products are undergoing transition in 2023 and 2024….

Read More

QuidelOrtho/ANZSBT 2023 Webinar Series to view

September 22, 2023

The QuidelOrtho/ANZSBT 2023 Webinar Series is now completed and we are very pleased to announce that this educational webinar series on a variety of topics in immunohematology is now available…

Read More

Blood Synergy Community Consultation Survey

August 24, 2023

This may be of interest to members. The Blood Synergy is undertaking a survey to identify the research questions of most interest and importance to the community. They are seeking…

Read More

NBA Patient Blood Management guideline for adults with…

August 14, 2023

The National Blood Authority (NBA) is pleased to announce that the Patient blood management guideline for adults with critical bleeding (the guideline) is now available. The guideline supersedes the 2011…

Read More

Prof Heimburger Award 2024: applications now open

August 14, 2023

This may be of interest to members. CSL have announced that applications for the Prof Heimburger Award 2024 opened on August 1, 2023. The Prof Heimburger Award is an annual…

Read More

ANZSBT Council Ballot

August 9, 2023

Voting is now open for ONE vacant position on Council for the 2023-2025 term. Members must have a membership with expiry date of 2024 and beyond. You will not be…

Read More

Update on the transition of Australia’s domestic SCIg…

July 26, 2023

This may be interest to members. The National Blood Authority is advising of the transition from Australia’s domestic subcutaneous immunoglobulin (SCIg) product EVOGAM to HIZENTRA AU. The new product will…

Read More